WORLD CANCER INSTITUTE Trademark

Serial Number: 85084859

WORLD CANCER INSTITUTE is a trademark filed by Unifund Corporation on July 14, 2010. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Class 16 - Paper Goods

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

Unifund Corporation (23 trademarks)

10625 Techwoods Circle
Cincinnati, OH 45242

Entity Type: 03

Trademark Details

Filing Date

July 14, 2010

Registration Date

Not Registered

Goods & Services

Educational services, namely, developing, arranging, and conducting educational conferences and programs for medical professionals in the field of treatments, products and scientific developments relating to the prevention, diagnosis and treatment of cancer

Digital media, namely, CD's and DVD's featuring information in the fields of longevity science and therapeutic treatment programs for the treatment of cancer

Publications

Providing a forum for medical professionals to showcase, demonstrate and discuss treatments, products and scientific developments in the field the prevention, diagnosis and treatment of cancer

Medical services, namely, providing clinical services and programs for the prevention and treatment of age-related degenerative disorders, cancer, inflammation, disorders of the nervous system and disorders of the immune system; providing epigenetic, hormonal, and immunotherapeutic treatment programs for the treatment of cancer

Medical and scientific research, namely, conducting clinical trials in the fields of age-related degenerative disorders, cancer, inflammation, disorders of the nervous system, disorders of the immune system, pharmaceuticals and genetics